Grant of Options
October 09 2007 - 11:07AM
UK Regulatory
RNS Number:4168F
Dermasalve Sciences PLC
09 October 2007
DERMASALVE SCIENCES PLC
GRANT OF OPTIONS AND DIRECTOR/PDMR SHAREHOLDING
Grant of Options
The Board of DermaSalve Sciences plc ("DermaSalve" or the "Company") announces
that on 9th October 2007 the Company granted the following options to subscribe
for ordinary shares of 1p each ("Ordinary Shares") to directors.
Director Options
Dr. Mark Randle, Chief Executive 1,666,666
Philip Pattison, Finance Director 4,166,666
Neil Wilson, Sales and Marketing Director 1,666,666
All of the options are exerciseable at a price of 15p per share between 10
October 2009 and 9 October 2017. The options were granted to Dr. Mark Randle
and Philip Pattison under the DermaSalve Unapproved Share Option Scheme and to
Neil Wilson under the DermaSalve Enterprise Management Incentives Scheme.
Director/PDMR Shareholding
The Company also announces that it was notified on 9th October 2007 that Clive
Morton OBE, Non-Executive Chairman, had on that day gifted 757,576 Ordinary
Shares to his adult daughters. Following this transaction, Clive Morton is
interested in 9,090 Ordinary Shares, representing 0.01 per cent. of the issued
share capital.
Enquiries
DermaSalve Sciences plc 0191 260 5070
Dr. Mark Randle
Phil Pattison
Hanson Westhouse Limited 0113 246 2610
Tim Feather
Matthew Johnson
Hansard Group 020 7245 1100
Brendan Adams
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSEKLFBDBBBFBZ
Dermasalve Sciences (LSE:DRM)
Historical Stock Chart
From Sep 2024 to Oct 2024
Dermasalve Sciences (LSE:DRM)
Historical Stock Chart
From Oct 2023 to Oct 2024